Evaxion Biotech A/S
EVAX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $90,766 | $468,536 | $1,048,966 | $2,153,992 |
| - Cash | $5,052 | $4,183 | $13,184 | $32,166 |
| + Debt | $10,101 | $10,870 | $10,255 | $3,690 |
| Enterprise Value | $95,815 | $475,223 | $1,046,037 | $2,125,516 |
| Revenue | $3,344 | $73 | $0 | $0 |
| % Growth | 4,480.8% | – | – | – |
| Gross Profit | $3,344 | $73 | $0 | $0 |
| % Margin | 100% | 100% | – | – |
| EBITDA | -$9,786 | -$21,403 | -$22,572 | -$24,207 |
| % Margin | -292.6% | -29,319.2% | – | – |
| Net Income | -$10,567 | -$22,125 | -$23,169 | -$24,532 |
| % Margin | -316% | -30,308.2% | – | – |
| EPS Diluted | -9.8 | -32.4 | -39.2 | -50.4 |
| % Growth | 69.8% | 17.3% | 22.2% | – |
| Operating Cash Flow | -$12,940 | -$17,691 | -$25,774 | -$21,933 |
| Capital Expenditures | $0 | -$87 | -$292 | -$1,360 |
| Free Cash Flow | -$12,940 | -$17,778 | -$26,066 | -$23,293 |